speaker-icon

Latest Posts

Partex-EDCC-collaboration-illustration

3

Jun 24

Partex and Singapore’s Experimental Drug Development Centre collaborate to bring forward an innovative approach for early drug discovery and development

Frankfurt, Germany, 3rd June 2024, 9am CET Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled...
Read More
Partex-Lupin-press-release-illustration

23

Apr 24

Partex Partners with Lupin to Revolutionize Drug Discovery through AI-Driven Asset Search and Evaluation

Frankfurt, Germany, 23 April 2024 – Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled to...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More

Archives: News

New Employee Joining

Innoplexus Announces Appointment of Stratos Davlos as Chief Technology Officer (CTO) and Senior Vice President

Hoboken, New Jersey, September 16, 2019- Innoplexus Inc., a subsidiary of Innoplexus AG, announced today the appointment of Stratos Davlos as Chief Technology Officer (CTO) and Senior Vice President. Mr. Davlos is a highly accomplished artificial intelligence and machine learning executive with over 20 years of leadership experience. Prior to joining Innoplexus, Mr. Davlos was …

Innoplexus Announces Appointment of Stratos Davlos as Chief Technology Officer (CTO) and Senior Vice President Read More »

Innoplexus_Bilanz

Traum aller Anleger

Innoplexus aus Eschborn und der Vermögensverwalter Acatis aus Frankfurt testen eine neue KI-Maschine für die Geldanlage. Der 21. März 2019 bleibt den Aktionären des Pharmakonzerns Biogen in schmerzhafter Erinnerung. Kurz vor Börsenbeginn hatte der in Cambridge, Massachusetts, aufgehende Stern am Biotech-Himmel die Investoren darüber unterrichtet, dass er eine klinische Studie mit seinem Alzheimer-Präparat „Aducanumab“ abbrechen …

Traum aller Anleger Read More »

New Employee Joining

Innoplexus Announces Appointment of Rita Kelley as Senior Vice President and Managing Director, USA

Hoboken, New Jersey, September 12, 2019 – Innoplexus Inc, a subsidiary of Innoplexus AG, Frankfurt, which has developed the most comprehensive, industry validated, AI-powered Drug Discovery and Development platform, announced today the appointment of Rita Kelley as Senior Vice President Corporate Development and Marketing. Rita will also act as Managing Director USA. Ms. Kelley is …

Innoplexus Announces Appointment of Rita Kelley as Senior Vice President and Managing Director, USA Read More »

Cures-Within-Reach

Innoplexus and Cures Within Reach for Cancer Tap the Power of Artificial Intelligence to Find Off-Patent Non-Cancer Drugs That Have Potential to Treat Cancer

Hoboken, NJ, August 5, 2019 – Innoplexus Holdings, Inc., a leader in artificial intelligence (AI) solutions for the life sciences industry, has partnered with the nonprofit Cures Within Reach for Cancer to pave the way for faster and more effective identification of new, affordable cancer treatments among existing non-cancer generic and off-patent drugs. Innoplexus is …

Innoplexus and Cures Within Reach for Cancer Tap the Power of Artificial Intelligence to Find Off-Patent Non-Cancer Drugs That Have Potential to Treat Cancer Read More »

pharmaceutical-technology

AI CTP engine estimated failure for Biogen’s aducanumab

While drug development can be incredibly lucrative, it is a very risky business. German company Innoplexus has developed a domain-specific AI prediction engine, which recently caught attention by correctly predicting that Biogen’s Alzheimer’s drug aducanumab would fail with 70% to 90% certainty. Allie Nawrat finds out more. In March 2019, Biogen’s long anticipated drug for …

AI CTP engine estimated failure for Biogen’s aducanumab Read More »

predicting-drug-flops

Predicting Drug Flops with AI

While drug development can be incredibly lucrative, it is a very risky business. German company Innoplexus has developed a domain-specific AI prediction engine, which recently caught attention by correctly predicting that Biogen’s Alzheimer’s drug aducanumab would fail with 70% to 90% certainty. Allie Nawrat finds out more. n March 2019, Biogen’s long anticipated drug for …

Predicting Drug Flops with AI Read More »

google-healthcare

Google for Healthcare

Gunjan Bhardwaj chose Germany as the place to launch his advanced search ­and discovery solution. His company assists the healthcare industry by organizing and analyzing vast amounts of data using ­artificial intelligence.

Academic-Access-Program

Innoplexus Launches Worldwide Academic Access Program for its Flagship Ontosight.ai

Frankfurt, Germany, May 21, 2019 — Innoplexus announced today the launch of Ontosight Academic, a platform that provides academic researchers free access to a vast volume of life sciences data made searchable using machine learning algorithms and other artificial intelligence technologies. Today, academic researchers in life sciences are swamped with millions of publications and theses …

Innoplexus Launches Worldwide Academic Access Program for its Flagship Ontosight.ai Read More »